$9.64
-3.8%DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Last Annual Value
235.00M
3-Year CAGR
-23%
5-Year CAGR
-18%
10-Year CAGR
-7%
| Company | Net Cash Provided by Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() DENTSPLY SIRONA Inc. NASDAQ:XRAY | 235.00M | -14.6% | -18.6% | -8.4% | |
![]() Agios Pharmaceuticals, Inc. NASDAQ:AGIO | -372.98M | N/A | N/A | N/A | |
![]() LeMaitre Vascular, Inc. NASDAQ:LMAT | 81.25M | 30.3% | 18.3% | 17.0% | |
279.40M | 6.0% | -0.8% | N/A | ||
![]() Haemonetics Corporation NYSE:HAE | 293.22M | 2.4% | 21.9% | 9.2% | |
![]() QuidelOrtho Corporation NASDAQ:QDEL | 105.20M | -27.9% | -33.4% | 24.4% | |
![]() ICU Medical, Inc. NASDAQ:ICUI | 179.85M | 2.7% | -7.6% | 7.2% | |
![]() Warby Parker Inc. NYSE:WRBY | 110.78M | 22.0% | N/A | N/A | |
![]() Beam Therapeutics Inc. NASDAQ:BEAM | -345.10M | N/A | N/A | N/A | |
![]() Recursion Pharmaceuticals, Inc. NASDAQ:RXRX | -371.81M | N/A | N/A | N/A |
Continue your XRAY research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.